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Critical determinants of combined sprint and endurance
performance: an integrative analysis from muscle fiber
to the human body
Stephan van der Zwaard,*,† Willem J. van der Laarse,‡ Guido Weide,*,† Frank W. Bloemers,§
Mathijs J. Hofmijster,† Koen Levels,† Dionne A. Noordhof,† Jos J. de Koning,† Cornelis J. de Ruiter,†
and Richard T. Jaspers*,†,1
*Department of Human Movement Sciences and †Laboratory for Myology, Faculty of Behavioural and Movement Sciences, and §Department
for Trauma Surgery, Amsterdam Movement Sciences, and ‡Department of Physiology, Institute for Cardiovascular Research, VU University
Medical Center Amsterdam, Amsterdam, The Netherlands
ABSTRACT:Optimizingphysicalperformance is amajor goal incurrentphysiology.However,basicunderstandingof
combining high sprint and endurance performance is currently lacking. This study identifies critical determinants
of combined sprint and endurance performance usingmultiple regression analyses of physiologic determinants at
different biologic levels. Cyclists, including 6 international sprint, 8 team pursuit, and 14 road cyclists, completed a
Wingate test and15-kmtime trial toobtain sprint andenduranceperformance results, respectively.Performancewas
normalized to lean body mass2/3 to eliminate the influence of body size. Performance determinants were obtained
fromwhole-body oxygen consumption, blood sampling, knee-extensormaximal force,muscle oxygenation,whole-
muscle morphology, andmuscle fiber histochemistry of musculus vastus lateralis. Normalized sprint performance
was explained by percentage of fast-type fibers andmuscle volume (R2 = 0.65;P < 0.001) and normalized endurance
performance by performance oxygen consumption (V̇o2),mean corpuscular hemoglobin concentration, andmuscle
oxygenation (R2 = 0.92; P < 0.001). Combined sprint and endurance performancewas explained by gross efficiency,
performance V̇o2, and likely by muscle volume and fascicle length (P = 0.056; P = 0.059). High performance V̇o2
related to a high oxidative capacity, high capillarization 3 myoglobin, and small physiologic cross-sectional area
(R2 = 0.67; P < 0.001). Results suggest that fascicle length and capillarization are important targets for training to
optimize sprint and endurance performance simultaneously.—VanderZwaard, S., van der Laarse,W. J.,Weide,G.,
Bloemers, F.W., Hofmijster,M. J., Levels, K., Noordhof, D. A., de Koning, J. J., de Ruiter, C. J., Jaspers, R. T. Critical
determinants of combined sprint and endurance performance: an integrative analysis from muscle fiber to the
human body. FASEB J. 32, 2110–2123 (2018). www.fasebj.org
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Many sports require a combination of sprint and endur-
ance performance. During the past decades, physiologic
determinants of physical performance have been the
subject of intensive investigation (e.g., in cycling, 1–11).
Studies focusedondeterminants of either sprint (e.g., 8–18)
or endurance performance (e.g., 1–7, 19–23), even though
physical performance is rarely a dichotomous function of
only sprint or only endurance. Generally, a limited num-
ber of whole-body determinants of sprint or endurance
performance have been studied, although there are many
physical performance determinants at different levels
(i.e., molecular, cellular, whole-muscle, organ, and whole
ABBREVIATIONS: 3D, 3-dimensional; CAF, capillaries around the fiber; CD, capillary density; C/F, capillary-to-fiber ratio; FCSA, fiber cross-sectional
area; fV̇o2max, fiber maximal oxygen consumption; [Hb], hemoglobin concentration; Hct, hematocrit; [HHbMb], deoxygenated hemoglobin and myo-
globin concentration; iSDH activity, spatially integrated SDH activity, SDH activity 3 FCSA; KE, knee-extension; LBM, lean body mass; Lf, fascicle
length; LT1/2, first/second lactate threshold; [Mb], myoglobin concentration; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular he-
moglobin concentration; MCV, mean corpuscular volume; MHC, myosin heavy chain; [O2HbMb], oxygenated hemoglobin and myoglobin concen-
tration; PCSA, muscle physiological cross-sectional area; performance V̇o2, average oxygen consumption during the 15-km time trial; PO2, oxygen
tension; POpeak, peak power output; POpeak + POTT, combined sprint and endurance performance; POTT, average power output during a 15-km time
trial; RBC, red blood cell; SDH, succinate dehydrogenase; UEA-1, Ulex europaeus agglutinin 1 lectin; VL, vastus lateralis; V̇o2max, maximal oxygen
consumption, VT1/2, first/second ventilatory threshold; Wmax, maximum workload
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body), which may interact. This increases the complexity
ofmaximizing performance and increases the complexity
of physiologic adaptations in response to training and/
or nutritional interventions. So far, most research has
addressed determinants of physical performance at the
organ orwhole-body level (e.g., in cycling, 1–11). Another
factor that adds to the complexity of optimizing physical
performance is that adaptations for endurance or peak
power are mutually exclusive, particularly in skeletal
muscle (24–26).
Prime determinants of physical performance in hu-
mans are skeletal muscle endurance andmaximal power-
generating capacity (25, 27). Muscle peak power is largely
determinedby themyosinheavychain isoformexpression
and muscle volume (e.g., 11, 12, 16–18, 28–31), whereas
(muscle) endurance capacity relies on mitochondrial oxi-
dative capacity and oxygen supply toward andwithin the
muscle (e.g., 1, 20–22, 27, 32–34). It is, however, generally
acknowledged that muscle fiber size and oxidative ca-
pacity are inversely related (25, 35). Apparently, these
are adapted such that oxygen demand and supply are
matched and that muscle fibers prevent hypoxia at maxi-
mal oxygen consumption (V̇o2max) (25, 36). Increasing
both fiber size and oxidative capacity is commonly
endeavored in sports and rehabilitation training, but
with limited success (24). Moreover, molecular signaling
pathways for mitochondrial biogenesis inhibit contractile
muscle protein synthesis (24–26). Improving both traits
simultaneously is, therefore, highly challenging. It has
been postulated that, to increase both fiber size and oxi-
dative capacity, one should enhance oxygen supply to-
ward and within the muscle fibers (25). That should
accommodate the increased oxygen diffusion distance
from capillaries to the mitochondria, resulting from in-
creases in fiber size (25). Given the interference among
determinants for peak power and endurance perfor-
mance, the question arises how to improve both traits
simultaneously.
An integrative approach assessing how physiologic
determinants are related to performance of top-level ath-
letes may provide new insights in the key determinants
and the most optimal combination of determinants for
combined sprint and endurance performance. For this
purpose, we assessed the critical determinants of sprint,
endurance, and combined sprint and endurance perfor-
mance in athletes using the explained variance by corre-
lation and multiple regression analyses. We assessed
sprint performance by peak power production and the
following determinants: muscle fiber size, muscle fiber
type, number of muscle fibers, and whole-muscle mor-
phology of musculus vastus lateralis (VL), blood lactate
concentration, maximal isometric torque, and specific
force. Endurance performancewas assessed during a time
trial with determinants: muscle fiber oxidative capacity,
muscle fiber type, oxygen supply toward muscle fiber
(reflected by capillaries and blood parameters) andwithin
muscle fiber [reflected bymyoglobin concentration (Mb)],
whole-muscle oxygenation of VL, blood lactate concen-
tration, whole-body oxygen consumption, and mechani-
cal gross efficiency. Maximal power of an organism is
scaled to its body size. To eliminate effects of body sizeand
to investigate only biologic differences in power pro-
duction, physical performance was normalized to lean
body mass (LBM). Cross-sectional studies among cyclists
are likely a useful model to investigate critical determi-
nants of combined sprint and endurance performance
because cycling disciplines focus on either optimization of
sprint, endurance, or on both sprint and endurance (38).
We assessed determinants of combined sprint and en-
durance performance in sprint, team pursuit, and road
cyclists because those cyclists were expected to have op-




Included in thestudywere28cyclists (14 road,8 teampursuit, and
6 track sprint). Cyclists [means6 SD: age, 256 7 yr;weight, 77.46
8.1 kg; height, 1.86 6 0.06 m, body–mass index, 22.4 6 1.9; lean
body mass, 68.8 6 6.0 kg; V̇o2max, 62.7 6 7.9 ml/kg/min, as
previouslydescribed (34)] competedat thenational, international,
or Olympic level, except for 4 amateur road cyclists. The study
was conducted according to the Declaration of Helsinki (2013)
and was approved by the VU Medical Center Ethics
Committee (NL49060.029.14). Subjects provided written,
informed consent and were instructed to avoid strenuous
exercise and alcohol consumption (,24 h) and to consume no
meals and caffeinated beverages (,3 h) before exercise testing.
Training specifics are described in Supplemental Data S1.
Whole-body cycling performance
For sprint performance, 1-s peak power output (POpeak) was
obtained from a 30-s Wingate test on a bicycle ergometer (Mon-
ark 894 E Peak Bike; Monark Exercise, Vansbro, Sweden). Sub-
jects received strong verbal encouragement and remained seated
throughout the test. Workload was applied after 2 revolutions
andwas set at 10% bodymass; 1min after exercise, blood lactate
concentration was obtained from the fingertip (Lactate Pro 2;
Arkray KDK, Kyoto, Japan). For endurance performance, we
obtained average power output during a 15-km time trial (POTT)
on an electronically braked bicycle ergometer (VU-MTO,
Amsterdam, The Netherlands). Power output was determined
from torque and cadence measurements sampled at 100 Hz.
Completed cycling distance was calculated as a function of
power output, rolling friction (mr = 0.003) and air friction (ma =
0.17), similar to road cycling. Subjects self-selected their pre-
ferredgear ratioandreceivedvisual andverbal feedbackon their
time trial progression.
To eliminate the influence of body size and to investigate
only biologic differences in power production (rather than
physical principles), physical performance was normalized to
LBM2/3 (37). Fat mass was obtained from the sum of 4 skin
folds (39).
Howwell individual cyclists were able to combine sprint and
endurance performance was expressed relative to the whole
group. Combined sprint and endurance performance (POpeak +
POTT ) was assessed by perpendicular residuals to the Deming
regression line between POTT and POpeak, that is, the perpen-
dicular projections of the data points onto that regression line as
seen in Fig. 2. Thus, perpendicular residuals equal the perpen-
dicular distances from individual data points to the Deming re-
gression line, which accounts for an error in both variables,
instead of error in variable y only. Those residuals quantify both
DETERMINANTS OF SPRINT AND ENDURANCE 2111
howmuchacyclist’s sprintperformancediffers fromhis expected
sprint performance (i.e., d between actual sprint performance and
predicted sprint performance based on the regression line and the
cyclist’s actual endurance performance) as well as howmuch en-
durance performance differs from the cyclists expected endurance
performance (i.e., d between actual endurance performance and
predictedenduranceperformancebasedon the regression lineand
cyclist’s actual sprint performance).
Whole-body oxygen consumption
Whole-body V̇o2 was obtained during the 15-km time trial and
during a maximal incremental exercise test (on a Monark Ergo-
medic 839E; Monark Exercise), and was recorded breath-by-
breath using open circuit spirometry (Cosmed Quark CPET;
Cosmed, Rome, Italy). Before testing, gas analyzer and volume
transducer were calibrated according to manufacturer’s instruc-
tions. Breath-by-breath data were smoothed and then averaged
over the time trial to obtain performance V̇o2. V̇o2max was cal-
culatedas thehighest 30-s valueandmaximumworkload (Wmax)
as the highest 3-min value achieved during the maximum-effort
incremental test to voluntary exhaustion. Initial workload was
80 W and increased by 40 W/3 min. Gross efficiency was cal-
culated for the last minute of each increment, dividing me-
chanical power by oxidative metabolic power and accounting
for power loss within the Monark transmission system (2).
Metabolic power was derived from V̇o2 and respiratory ex-
change ratio (40). Highest gross efficiency was obtained with
respiratory exchange ratio, 1.0 and V̇o2 in steady state [,5%
change between min 2 and 3 of each increment (40)]. V̇o2 at
ventilatory thresholds (VT1 and VT2) and lactate thresholds
(LT1 and LT2) were obtained from 30-s moving averages. VT1
was determined using the V-slope method and ventilatory
equivalents (41), and VT2 was derived from minute ventila-
tion vs. V̇co2 plots and ventilatory equivalents (42). Blood
lactate concentration was obtained at the end of each in-
cremental step, andvalueswere linearly interpolated toretrieve
LT1atablood lactateof2mMandLT2at4mM(43). V̇o2andWmax
values were also normalized to LBM2/3.
Muscle oxygenation
Changes in deoxygenated hemoglobin + [Mb] ([HHbMb]) and
oxygenated hemoglobin + [Mb] ([O2HbMb]) were measured
with respect to the start of the 15-km time trial, using a
continuous-wavelength near-infrared spectroscopy device
(Portamon; Artinis Medical Systems, Elst, The Netherlands),
according to Van der Zwaard et al. (44).
Maximal isometric knee-extension torque
Maximal isometric knee-extension (KE) torque of the right leg
wasmeasured using a custom-made dynamometer. Active knee
flexion angle was set at 60° during submaximal activation, after
aligning the subject’s anatomic knee axis with the dynamometer
rotation axis, and hip flexion angle was set at 85° (full extension
equals 0°). The lower leg was protected by a shin guard and
strapped toa force transducer (KAPE/200Hz;Bienfait,Haarlem,
The Netherlands), placed 26.6 cm distally from the knee joint,
and subjects were firmly secured with straps over hips and
shoulders.Afterwarm-up, subjects performed 4–5 attempts to
attain maximal isometric KE torque, receiving online visual
feedback on their force tracings. KE torque was obtained after
multiplication ofmeasured forces (sampled at 1 kHz)with the
lever arm. Maximal isometric KE torque was calculated as
highest 100-ms average obtained during the 5-s isometric
contractions.
Whole-muscle morphology
Whole-muscle VLmorphology was examined by 3-dimensional
(3D) ultrasound (45). Briefly, the hip flexion angle was set at 85°
and knee flexion angle at 60°. B-mode ultrasound images were
collected at 25 Hz during multiple scans of the right VL using a
5-cm linear probe in longitudinal or transverse orientation
(Technos MPX; Esaote, Firenze, Italy). Location and orientation
of the probe were registered by a motion capture system (Opto-
trak Certus; Northern Digital, Waterloo, ON, Canada) and syn-
chronizedwith ultrasound images to construct a 3D voxel array,
using customized software (MatLab; MathWorks, Natick, MA,
USA).DistalVLmusclebelly endandproximal attachment to the
trochanter major were identified by open-source, 3D image-
processing software (Medical Imaging Interaction Toolkit; http://
www.mitk.org). VL muscle volume was measured between these
anatomic landmarks by manual segmentation of the anatomic
cross-sections and subsequent interactive interpolation in medi-
cal imaging software. Fascicle length (Lf) and pennation angle
between fascicle and distal aponeurosis (u) were assessedwithin
the midlongitudinal fascicle plane at a position two-thirds of the
way along the muscle belly (distal from the origin). Physiologic
cross-sectional area (PCSA) was calculated by dividing muscle
volume by Lf. PCSA was multiplied by cosine u to provide the
effective PCSA (46).
Specific force of the VL was estimated using KE isometric
torque, optimal patellar moment arm (dPT), the contribution of
VL to musculus quadriceps femoris and effective PCSA. The dPT
is very similar between subjects [means, 4.7–4.8 cm (46, 47)] and
was assumed to be 4.75 cm in all cyclists. Because VL volume is
;34%of the total quadriceps femoris volume in cyclists (48), and
that percentage is similar for PCSA and volume (47), VL specific
force was estimated using Eq. 1:






Resting blood samples were collected in EDTA-coated Vacu-
tainer tubes (BD Biosciences, Franklin Lakes, NJ, USA) by veni-
puncture and analyzed for red blood cells (RBCs), hemoglobin
concentration ([Hb]), hematocrit (Hct), mean corpuscular vol-
ume (MCV), mean corpuscular hemoglobin (MCH), and mean
corpuscular hemoglobin concentration (MCHC). Hct was de-
termined by microhematocrit analysis.
Muscle biopsy samples
Biopsies were obtained from the right VL, as described pre-
viously (34). In brief, muscle biopsies were collected after local
anesthesia;15 cm above the patella at a depth of;4 cm. Biopsy
samples were aligned to muscle fiber arrangement, frozen in
liquid nitrogen, and cut in 10-mm-thick sections using a cryostat
at220°C.Sectionswerecollectedonpolylysine-coated slidesand
stored at280°C until further analysis.
Muscle fiber histochemistry
Fiber-type composition was obtained by immunofluorescence
analysis of myosin heavy chain (MHC) expression (49), using
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primary antibodies BA-D5, SC-71, and 6H1 and secondary an-
tibodies Alexa Fluor 488 IgG2b, 488 IgG1, and 647 IgM (all from
Developmental Studies Hybridoma Bank, Iowa City, IA, USA).
Fiber-type distribution (type I, I/IIA, IIA, IIAX, and IIX) was
manually determined from 388 6 142 fibers per subject
(mean 6 SD).
Mitochondrial oxidative capacity was assessed by succinate
dehydrogenase (SDH) activity determined using quantitative
histochemistry (50, 51). SDH activity of the biopsy was de-
termined from absorbance measurements at 660 nm using fiber
type distribution and spatially averaged SDHactivity, including
subsarcolemmal mitochondria, of 516 11 randomly selected fi-
bers (range, 36–79) in ImageJ software (National Institutes of
Health, Bethesda, MD, USA) (34, 52). SDH activity was used to
calculatemuscle fiber oxidative capacity (fV̇o2max, in nmol/mm
3
per second)andwhole-bodyoxidativecapacity, according tovan
der Zwaard et al. (34). Whole-body oxidative capacity was nor-
malized to LBM2/3.
Fiber cross-sectional area (FCSA)was determined from fiber-
type distribution and manually segmented FCSA of 51 6 11
randomly selected fibers. Fiber circularity was calculated as
shown in Eq. 2:
4p3 FSCA
ðPerimeterÞ2 (2)
and longitudinally cut fibers were excluded from analysis [i.e.,
circularity, 0.60 in accordancewith Verdijk et al. (53)]. Average
circularity was 0.79 6 0.03. PCSA reflects the cross-sectional
area of all fibers, including interstitial space and connective
tissue. An estimate of muscle fiber number of the VL was
providedbydividing thePCSA (from3Dultrasound imaging)
by average FCSA. Average SDH activity was multiplied by
average FCSA to obtain spatially integrated SDH (iSDH)
activity.
Capillarization was assessed by staining forUlex europaeus
agglutinin 1 lectin (UEA-1; Vector Laboratories, Burlingame,
CA, USA) (54). Sections (10 mm) were air-dried, fixed in ace-
tone at220°C for15min,blockedwith1%bovineserumalbumfor
30 min, and incubated at room temperature for 30 min with bio-
tinylated UEA-1 (20 mg/ml). Subsequently, sections were incu-
bated for 30 min with Vectastain Elite ABC Kit PK-6100 (Vector
Laboratories) and incubated for 30 min with red peroxidase sub-
strate SK-4285 (Immpact Amec; Vector Laboratories). Capillaries
were analyzed for capillary-to-fiber ratio (C/F), capillaries around
each fiber (CAF), and capillaries per square millimeter of muscle
tissue [capillary density (CD)]. Muscle fibers and capillaries were
counted from 3 photomicrographs of the biopsy section. For the
C/F ratio,muscle fiber fragments cut by the left anduppermargins
and associated capillaries were rejected and those cut by right and
lower margins were included in the analysis. Longitudinally cut
capillaries were counted as 1 at each muscle fiber junction (55). On
average, 2656 95 capillaries and 946 35 muscle fibers were ana-
lyzed per subject.
The [Mb] was determined by calibrated histochemistry (52,
56). Absorbance was measured at 436 nm (52). Peroxidase ac-
tivity of hemoglobin was excluded from measurements. The
[Mb] was obtained after calibration using gelatin sections con-
taining known concentrations of horse myoglobin.
Analysis of histochemistry images is described in Supplemental
Data S2.
Statistical analysis
Results are expressed as means 6 SD. Relationships between
normalized sprint and endurance performance, between ranked
normalized sprint and endurance performance, and between fi-
ber size21 and fiber oxidative capacitywere assessed byDeming
linear-regressionanalysis. Perpendicular residuals to theDeming
regression lines were used to quantify POpeak + POTT or the
combination of FCSA21 and fV̇o2max (FCSA-1 was used to take
into account the hyperbolic relationship between these two var-
iables; for details see the last paragraph of the section on whole-
body cycling performance). Coefficients of determination were
obtained for normalized sprint, endurance, and combined sprint
and endurance performance by Pearson’s correlations and step-
wise multiple-regression analysis. Predictors were included in
the model if a significant R2 change (P , 0.05) was reported.
Results were considered significant if P, 0.05. Tendencies were
also reported if P, 0.10.
RESULTS
Sprint and endurance performance
Table 1 shows values for sprint performance, endur-
ance performance, and physiologic performance de-
terminants, whereas muscle fiber histochemistry was
displayed in Fig. 1. The relationship between sprint
and endurance performance per kilogram body mass
was inverse (r = 20.44; P , 0.05). An even more-
pronounced inverse relationship was shown between
POpeak and POTT normalized to LBM
2/3 (r =20.66; P,
0.001, Fig. 2). Normalized sprint and endurance per-
formance largely differed among cyclists, up to 1.5-
fold and 2-fold differences, respectively. Substantial
variation among subjects was also observed for com-
bined sprint and endurance performance (POpeak +
POTT), reflected by perpendicular residuals. The cy-
clist with the highest POpeak + POTT was an Olympic
track cyclist competing at the highest performance
level. These results indicate that the observed varia-
tion in combined sprint and endurance performance




We assessed how physiologic determinants contribute
to the explained variance in normalized sprint perfor-
mance (Fig. 3). Normalized sprint performance was
explained by VL muscle volume, percentage of fast-
type fibers, PCSA, blood lactate concentration, and KE
maximal torque. Focusing on muscle architecture,
track sprinters revealed different arrangements of
their PCSA and Lf compared with the other cyclists:
sprinters had a relatively large PCSA (82 6 14 cm2)
compared with team pursuit and road cyclists (586 9
cm2), whereas their fascicle lengthswere similar (9.66
1.3 and 10.1 6 1.7 cm, respectively). A large PCSA
tended to be associated with large pennation angles
(r = 0.34; P = 0.08), whereas a long Lf was associated
with relatively small pennation angles (r =20.46; P,
0.05). PCSA was related to FCSA of both type I and II
fibers (r = 0.56, P , 0.01; and r = 0.74, P , 0.001, re-
spectively). In the subgroup of team pursuit and road
cyclists, Lf and specific force also significantly con-
tributed to normalized sprint performance. Multiple-
regression analyses showed that the percentage of
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fast-type fibers and VL muscle volume together
explained 65% of variance in normalized POpeak for
the entire group, whereas 48% of the variance in nor-
malized POpeak was explained by the percentage of
fast-type fibers and Lf in the subgroup of team pursuit
and road cyclists. These results indicate that the major
determinants of normalized sprint performance are a
high percentage of fast-type fibers, large muscle vol-
ume, and long muscle fibers.
Determinants of normalized
endurance performance
Normalized endurance performance was explained
by gross efficiency, performance V̇o2, V̇o2max, V̇o2LT2,
V̇o2VT2, and whole-body oxidative capacity (Fig. 3).
Among blood parameters, MCH, MCHC, and MCV
determined normalized POTT rather than [Hb], Hct,
and RBC content. For VL parameters, the percentage
TABLE 1. Determinants of sprint performance and endurance performance
Determinant All
Road cyclists
Team pursuit Track sprinters RangeAmateur International
Whole-body
POTT (W) 344 6 52 316 6 20 363 6 39 376 6 45 291 6 47 233–431
POpeak (W) 1327 6 197 1380 6 89 1203 6 147 1256 6 151 1592 6 95 993–1685
Performance Vȯ (L/min) 4.29 6 0.52 4.03 6 0.15 4.49 6 0.38 4.54 6 0.56 3.80 6 0.48 3.09–5.45
V ȯ2max (L/min) 4.81 6 0.43 4.52 6 0.23 4.99 6 0.37 4.93 6 0.53 4.53 6 0.27 4.11–5.65
V ȯ2LT1 (L/min) 3.48 6 0.57 3.25 6 0.38 3.54 6 0.46 3.68 6 0.77 3.26 6 0.55 2.57–4.82
V ȯ2VT1 (L/min) 3.64 6 0.41 3.28 6 0.11 3.66 6 0.18 3.98 6 0.50 3.39 6 0.33 2.93–4.53
V ȯ2LT2 (L/min) 4.18 6 0.51 3.79 6 0.39 4.32 6 0.37 4.43 6 0.56 3.89 6 0.52 3.08–5.32
V ȯ2VT2 (L/min) 4.19 6 0.45 3.87 6 0.09 4.29 6 0.42 4.44 6 0.50 3.91 6 0.34 3.34–5.13
Wmax (W)
a 399 6 44 357 6 29 408 6 35 428 6 48 373 6 25 322–492
Gross efficiency (%) 21.9 6 1.0 20.7 6 0.2 22.4 6 0.8 22.2 6 1.1 21.5 6 0.7 20.2–24.1
Muscle
[O2HbMb] (AU) 213.3 6 6.2 213.7 6 2.9 214.4 6 7.7 212.7 6 6.6 212.0 6 5.3 231.0 to 22.6
[HHbMb] (AU) 14.5 6 7.6 19.5 6 14.7 14.0 6 7.1 14.7 6 5.2 11.6 6 4.7 5.3–39.0
KE torque (N × m) 301 6 56 310 6 28 294 6 44 284 6 72 329 6 64 202–447
Specific force (N × cm2) 35.4 6 7.9 42.5 6 6.3 37.6 6 6.1 33.1 6 8.5 29.9 6 7.2 21.8–49.5
Volume (cm3) 625 6 136 573 6 62 545 6 81 631 6 151 787 6 88 404–892
PCSA (cm2) 63.4 6 14.1 53.0 6 7.3 57.1 6 10.2 62.3 6 7.1 82.3 6 13.6 46.1–97.1
Lf (cm) 10.0 6 1.7 10.9 6 0.5 9.6 6 1.2 10.2 6 2.6 9.6 6 1.3 7.6–14.3
Pennation angle (deg) 15.5 6 3.3 14.3 6 2.9 15.0 6 3.5 14.9 6 2.4 18.0 6 3.8 10.7–22.4
Blood
[Lactate]postWingate (mM) 14.9 6 2.7 14.2 6 2.0 13.2 6 2.7 15.8 6 2.0 17.1 6 1.9 9.3–19.6
[Lactate]post-TT (mM) 13.0 6 4.1 14.7 6 3.7 14.4 6 2.4 13.0 6 5.3 9.7 6 3.7 8.0–20.3
RBC (1012/L) 5.2 6 0.4 5.3 6 0.4 5.1 6 0.4 5.2 6 0.5 5.3 6 0.5 4.4–6.2
[Hb] (mM) 9.6 6 0.7 9.5 6 0.9 9.7 6 0.6 9.7 6 0.7 9.4 6 0.7 8.4–10.9
Hct (%) 45.8 6 3.0 46.3 6 3.1 45.7 6 2.7 45.4 6 3.2 46.3 6 3.8 40.0–53.0
MCV (fL) 88.5 6 2.9 87.3 6 1.0 90.1 6 3.0 88.3 6 3.0 86.8 6 2.4 83–94
MCH (amol) 1856 6 101 1801 6 76 1910 6 95 1884 6 82 1776 6 79 1638–2091
MCHC (mM) 21.0 6 0.7 20.6 6 0.9 21.2 6 0.6 21.4 6 0.5 20.3 6 0.4 19.7–22.3
Muscle fiber
MHC type I (%) 67.3 6 11.8 52.4 6 11.2 72.1 6 10.8 73.3 6 7.7 61.3 6 7.8 41.7–88.8
MHC type II (%) 32.7 6 11.8 47.6 6 11.2 27.9 6 10.8 26.7 6 7.7 38.7 6 7.8 11.2–58.3
FCSA (mm2) 6600 6 1530 5847 6 1341 6176 6 1383 6679 6 1725 7702 6 1296 3354–9568
Fiber number (3106) 0.986 6 0.199 0.933 6 0.19 0.961 6 0.23 0.976 6 0.22 1.075 6 0.14 0.648–1.38
fVȯ2max (nmol/mm
3/s) 0.13 6 0.02 0.13 6 0.01 0.14 6 0.02 0.14 6 0.01 0.12 6 0.01 0.10–0.18
Oxidative capacity
(ml/kg/min)
67.2 6 8.8 65.8 6 6.3 70.3 6 9.5 71.7 6 2.9 56.7 6 5.8 47.0–91.6
iSDH activity, DA660 (mm/s) 0.147 6 0.034 0.131 6 0.033 0.140 6 0.023 0.157 6 0.044 0.156 6 0.035 0.093–0.229
[Mb] (mM) 0.38 6 0.04 0.37 6 0.05 0.39 6 0.03 0.38 6 0.03 0.36 6 0.04 0.31–0.44
CD (caps × mm2) 498 6 97 437 6 116 531 6 94 546 6 77 420 6 49 327–769
C/F (caps/fiber) 2.9 6 0.4 2.4 6 0.3 2.9 6 0.3 3.2 6 0.5 2.8 6 0.4 2.0–3.8
CAF (caps/fiber) 7.2 6 1.0 6.1 6 0.9 7.3 6 0.8 7.9 6 0.9 6.9 6 0.7 5.2–9.4
[Mb] 3 C/F
(mM × cap × fiber21)
1.1 6 0.2 0.9 6 0.2 1.2 6 0.2 1.2 6 0.2 1.0 6 0.2 0.7–1.4
[Mb] 3 CAF
(mM × cap × fiber21)
2.7 6 0.5 2.2 6 0.3 2.9 6 0.4 3.0 6 0.4 2.5 6 0.3 2.0–3.7
[Lactate]post-TT, blood lactate concentration 1 min after the time trial; [Lactate]postWingate, blood lactate concentration 1 min after the
Wingate test; oxidative capacity, whole-body oxidative capacity calculated from fVȯ2max according to van der Zwaard et al. (34); performance V̇o2,
oxygen consumption during the time trial; specific force, F/PCSA (Eq. 6.1); Wmax, maximal work rate (3-min average during a 3-min incremental
protocol, accounting for power loss within the Monark transmission system. aValue is expected to be lower than a Wmax obtained from ramp or
short, incremental, stepwise protocols).
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of slow-type fibers, fiber V̇o2max, C/F, CD, CAF, and
the interaction of [Mb] with C/F and CAF contributed
to normalized POTT, whereas [Mb] showed a tendency
(P = 0.068). Multiple-regression analysis revealed that
performance V̇o2, MCHC and [O2HbMb] together
explained 92% of the variance in normalized endur-
ance performance. Whole-body performance V̇o2 is a
major determinant of normalized POTT and was
explained by whole-body V̇o2max and V̇o2LT2 (R
2 =
0.93;P, 0.001) or byVLparametersmuscle fiber V̇o2max,
the interactionof [Mb]withC/F, andPCSA(R2=0.67;P,
0.001; Eq. 3). Gross efficiencywas positively related to the
percentage of slow-type fibers (r=0.45;P, 0.05), C/F (r=
0.50; P , 0.01), and CAF (r = 0.42; P , 0.05). The results
indicate that a high normalized-endurance performance
was achieved with a high performance V̇o2 (i.e., high
muscle fiber oxidative capacity, high [Mb], many capil-
laries per fiber, and a small PCSA) and a high oxygen-
supply capacity in the circulation (i.e., MCHC and
[O2HbMb]):
Performance  V ȯ2 ¼ 5583 fV ȯ2max þ 1033 ½Mb
3C=F2 0:783PCSA þ 117 (3)
Determinants of combined sprint and
endurance performance
POpeak+POTTwasexplainedbywhole-bodyperformance
V̇o2 and gross efficiency and showed a tendency with VL
Figure 1. Immunohistochemical staining for myofibrillar MHC type I, IIA, and IIX expression (A–C, G–I) and enzyme
histochemistry of SDH activity (D, J ), UEA-1 lectin for capillaries (E, K), and myoglobin concentration (F, L) from an Olympic
track cyclist (A–F) and amateur road cyclist (G–L), respectively. Cross sections of 10 mm were obtained from the human musculus
vastus lateralis. Muscle fiber type I, IIA, and IIAX are identified (A–L); type IIX was not present in the Olympic track cyclist (C).
Capillaries are indicated by arrows in 1 muscle fiber, indicating capillaries were more prominent in the Olympic cyclist compared
with the amateur road cyclist (E, K). Histochemical assays for myoglobin (F, L) contain black spots because of peroxidase activity
of hemoglobin, which was excluded from analysis. Scale bars, 100 mm.
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volume and Lf (P = 0.056; P = 0.059, respectively; Fig. 3).
Arrangement of Lf and PCSA differed between track
sprinters and other cyclists (as described above). Therefore,
Lf may have explained less variance in POpeak + POTT in the
whole group comparedwith the subgroup of team pursuit
and road cyclists (R2 = 0.13 and R2 = 0.25, respectively). In
thewhole group, 30%of the variance in POpeak + POTTwas
explained by gross efficiency and VL volume. In the sub-
groupof teampursuit and roadcyclists, 49%of thevariance
inPOpeak+POTTwas explainedbyperformance V̇o2andLf.
Whole-musclearchitecturemaybe important forPOpeak+
POTT. Lf explained 13–25%of the variance in POpeak + POTT,
whereas PCSAwas not related to POpeak + POTT.Moreover,
PCSA negatively affected performance V̇o2 (Eq. 3), which
was a main determinant of combined sprint and endurance
performance. These results suggest that, for VL, a long Lf,
rather than a large PCSA, is likely beneficial for obtaining a
high combined sprint and endurance performance.
Muscle fiberCSAandmuscle fiber V̇o2maxwere studied
in more detail. They showed an inverse, hyperbolic re-
lationship (r = 20.50; P , 0.01; Fig. 4), which illustrates
that it is difficult to simultaneously obtain a large FCSA
and a high muscle-fiber V̇o2max. How well the cyclists
combined a large fiber size with a high oxidative capacity
was assessed in absolute terms and relative to the group
[i.e., by the product of FCSA and fV̇o2max (iSDH activity)
and by perpendicular residuals of FCSA21 and fV̇o2max,
respectively] (Fig. 4). Itwas expected theoretically that high
muscle-fiber oxygen demands (i.e., high iSDH activity or
high residuals)werematched by enhanced oxygen-supply
capacity toward and within the muscle fiber. Our results
show that iSDH activity was indeed positively related to
capillarization (C/F: r = 0.58, P, 0.001; CAF: r = 0.53, P,
0.01), but not to RBC, [Hb],Hct, and other bloodmarkers
(P.0.10). IntegratedSDHactivitywasnot related to [Mb]
(r =20.24; P = 0.23). Similarly, perpendicular residuals of
FCSA and fiber V̇o2max were positively related to capil-
larization (C/F: r = 0.57, P, 0.001 and CAF: r = 0.52, P,
0.01), and showed a tendency with MCV (r = 0.36, P =
0.06), but were not related to RBC, [Hb], Hct and other
blood markers (P . 0.10). Residuals were not related to
[Mb] (r = 20.19; P = 0.33). Although fiber size and fiber
oxidative capacity were inversely related, cyclists may
combine a relatively large fiber size and a high oxidative
capacity with enhanced capillarization.
Normalized sprint andenduranceperformance, aswell
as FCSA and fV̇o2max, were inversely related (Figs. 2 and
4). Perpendicular residuals of both regression lines were,
however, not related (Table 2). This finding may relate to
muscle fiber number because athletes with many mus-
cle fibers have less need for combining high FCSA and
fV̇o2max: muscle fiber number was negatively related to
perpendicular residuals of FCSA and fV̇o2max (r = 20.41;
P , 0.05). Perpendicular residuals showed a positive
Figure 2. Normalized sprint and endurance performance are inversely related. Sprint performance (POpeak) and endurance
performance (POTT) were normalized to LBM
2/3. A) Normalized POpeak and POTT demonstrated an inverse relationship (POTT =
20.39 3 POpeak + 51), which was obtained with Deming regression analysis, accounting for errors in both variables. Individual
data is provided for track sprinters (downward triangle), team pursuit cyclists (upward triangle), (inter)national road cyclists
(black circle), and amateur road cyclists (gray circle). How well individual cyclists were able to combine sprint and endurance
performance relative to the whole group (POTT + POpeak) was assessed by perpendicular residuals to the regression line between
POTT and POpeak. These residuals quantify both how much a cyclist’s sprint performance differs from his expected sprint
performance (i.e., d between actual sprint performance and predicted sprint performance based on the regression line and
cyclist’s actual endurance performance) as well as how much endurance performance differs from his expected endurance
performance (i.e., d between actual endurance performance and predicted endurance performance based on the regression line
and cyclist’s actual sprint performance). B) Ranked, normalized POpeak and POTT also demonstrated an inverse relationship, as
obtained with Deming regression analysis.
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relationship with endurance performance, performance
V̇o2, V̇o2max, V̇o2 at lactate, and ventilatory thresholds and
showed a tendency with gross efficiency (Table 2).
Therefore, combining high FCSA and fV̇o2max did not di-
rectly relate to high POpeak + POTT, likely because of
muscle fiber number but was associated with enhanced
(determinants of) endurance performance.
DISCUSSION
This study integrates physiologic performance determi-
nants at different biologic levels, from cell to whole body,
to obtain insights in the critical determinants of normal-
ized sprint, endurance, and combined sprint and endur-
anceperformance.Weshowthat thepercentageof fast-type
fibers and muscle volume explain 65% of the variance
in normalized sprint performance and that performance
V̇o2 and oxygen supply within the circulation (MCHC
and [O2HbMb]) explain 92% of the variance in normalized
endurance performance. Combined sprint and endurance
performance was explained by gross efficiency, perfor-
mance V̇o2, and likely by VL volume and Lf. The results
indicate that, for VL, a long fascicle rather than a large
PCSA is likely beneficial for achieving high POpeak + POTT.
Although normalized sprint and endurance performance
Figure 3. Determinants of normalized combined sprint and endurance performance. Sprint performance (POpeak) and
endurance performance (POTT) were normalized to LBM
2/3. Combined sprint and endurance performance (POpeak + POTT)
was reflected by perpendicular residuals of the regression line between POpeak and POTT (Fig. 2). Bars indicate significant
determinants of (combined) sprint and endurance performance in cyclists and their explained variance (% r2) obtained from
Pearson’s correlations. Black bars indicate significant determinants (P , 0.05), and gray bars indicate a tendency (P , 0.10).
*White bars illustrate significant determinants (P , 0.05) in a subgroup of team pursuit and road cyclists. Multiple-regression
analyses revealed a combination of predictors, which are presented at the bottom of each panel. Whole-muscle and muscle-fiber
determinants were obtained from the musculus vastus lateralis. Specific force, F/PCSA or KE force per physiologic cross-sectional
area; [Lactate]postWingate, blood lactate concentration 1 min after the Wingate test; MHC type II, myosin heavy chain type II
proportion or proportion of fast-type fibers; # fibers, estimated muscle fiber number; [Lactate]post TT, blood lactate concentration
1 min after the time trial.
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as well as muscle-fiber size and muscle-fiber oxidative
capacity were inversely related, cyclists succeeded at
combining relatively large FCSA and high fV̇o2max with
enhanced capillarization.
Physiology of sprinters: high normalized
sprint performance requires long and fast
muscle fibers
We show that VL muscle volume and the percentage of
fast-type fibers explain 65% of the variance in normalized
POpeak.That findingwasnotunexpectedbecauseprevious
data demonstrated that both muscle volume and fiber-
type distribution are important for cycling peak power
production (11). Peak power output during cycling could
be predicted by lean body mass (16), lean leg volume (16,
30), and lean thigh volume (57). Certainly, increases in
muscle mass will improve peak power production by the
muscle, irrespective of its fiber-type distribution. The
proportion of fast-type fibers is also critical to peak power
production because it determines maximal muscle-fiber
contraction velocity (27, 58, 59). Optimal pedaling velocity
during sprint cycling has been shown to relate to the
proportion of fast-type fibers in musculus vastus lateralis
(30) and their proportion of the cross-sectional area (31). In
linewith those data, the product of lean thigh volume and
optimal pedaling rate (i.e., a proxy measure for fiber-type
distribution) explained 83% of the variance in maximal
power across the life span [from 8 to 70 yr (29)]. Although
sprint performance was normalized to LBM2/3 to remove
the influence of body size, muscle volume was still a sig-
nificant predictor of normalized POpeak. Thismay indicate
that large VL volume also contributes to biologic differ-
ences in power production, possibly by distributing
musclemass toward locomotorymuscles or by increasing
thepercentageofmusclemass. Theproportion of fast-type
fibers is also associatedwith anaerobic energy production.
Lactic acid production explains a large proportion of var-
iance in sprintperformance, accounting for approximately
one-half of energy demands during a Wingate (60). Al-
thoughblood lactate concentrationwashigher in our track
sprinters (17.161.9mM)comparedwith teampursuit and
road cyclists (14.2 6 2.5 mM), it explained only 16% of
normalized POpeak, likely because it only reflects part of
the total lactate production (61, 62). The results confirm
that the percentage of fast-type fibers and VL muscle
volume were the critical determinants of normalized
sprint performance.
The question is whether VL muscle architecture influ-
ences normalized sprint performance. Arrangement of
PCSAandLf differedbetween the track sprinters andother
cyclists, revealing amuch larger PCSAbut similar Lf in the
track sprinters. A long fascicle length (i.e., high numbers of
sarcomeres in series)has theoreticallybeenassociatedwith
high maximal muscle-fiber contraction velocity (63) and
has been shown to relate to better sprint performance (14,
15). PCSA is increased bymuscle-fiber hypertrophy and is
thought to result in proportional increases in maximal
muscle force (27, 64), assuming that specific force (F/
PCSA) remains constant. However, knee-extensor specific
force in our track sprinters (306 7N × cm2)was lower than
that of the other cyclists (386 7N × cm2), and similar to that
of healthy males (46). Specific force of track sprinters may
have been reduced because their larger PCSAs showed a
tendency toward larger pennation angles, reducing force
exertionwith respect to the line of pull (65). These findings
may also explain why peak power per kilogram body
mass of our track sprinters was lower than that of elite
track sprinters [18.36 1.3W/kg comparedwith 19.3–20.8
W/kg (66–68)], even though absolute sprint performance
was similar [1592 6 95 W (66, 67)]. Results show that an
optimal normalized sprint performance requires fast
muscle fibers, a large muscle volume, and muscle archi-
tecture with long Lf rather than a large PCSA.
Figure 4. fVȮ2max and FCSA demonstrate an inverse hyperbolic
relationship (i.e., fVȮ2max = –366 3 –FCSA
21 + 0.076), which
was obtained with Deming regression analysis that accounts for
errors in both variables. Individual data is provided for track
sprinters (downward, filled triangle), team pursuit cyclists
(upward, filled triangle), (inter)national road cyclists (black,
filled circle), and amateur road cyclists (gray, filled circle).
How well individual cyclists were able to combine fVȯ2max and
FCSA relative to the whole group was assessed by perpendicular
residuals to the hyperbolic regression line between fVȯ2max
and FCSA.
TABLE 2. Relationships between perpendicular residuals of FCSA
and f V̇o2max and whole-body performance, oxygen consumption,
and efficiency
Determinant Correlation coefficient P
POTT 0.46 ,0.05
POpeak + POTT 0.15 0.45






Gross efficiency 0.36 0.06
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Physiology of endurance cyclists: high
normalized endurance performance
requires high performance V̇o2
Normalized endurance performance was almost fully
explained by performance V̇o2, and O2 supply capacity in
the circulation (MCHC and [O2HbMb]). Whereas current
literature predominantly reports whole-body determinants
of endurance performance (1–3, 6–9, 19), we assessed how
whole-body performance V̇o2 was explained by oxygen
demand and oxygen supply within the muscle. To our
knowledge, this study is the first to show that variance in
performance V̇o2 is explained by muscle-fiber oxidative ca-
pacity, oxygen supply capacity toward and within the
muscle fiber ([Mb]3 C/F), and physiologic cross-sectional
area of the muscle (R2 = 0.67). These results suggest match-
ingbetweenO2supplyanddemandat themuscle-fiber level
(Q̇o2/V̇o2 matching) and demonstrate the detrimental
effect of muscle hypertrophy (i.e., increase in PCSA) on av-
erage oxygen consumption during the endurance perfor-
mance. The importance of Q̇o2/V̇o2 matching is also
indicated by a higher [O2HbMb] concentration during the
time trial, reflecting lower oxygen extraction. High normal-
ized endurance performance requires matching of O2 de-
mand and O2 supply, preferably with a small PCSA.
Gross efficiency explained 36% of the variance in nor-
malized POTT and was associated with a high percentage
of slow-type fibers, similar to previous observations in
competitive cyclists (69). Maximal efficiency of type I and
type IIA fibers is similar (70); however, type I fibers attain
their peak efficiency at lower shortening velocities (70).
Accordingly, it has been suggested that a large proportion
of slow-type fibers results in ahigher efficiencyat common
cycling cadences [i.e., 602120 rpm (1)]. Gross efficiency
was also associated with C/F and CAF. Note that gross
efficiency was not obtained at fixed exercise intensity but
at exercise intensity just below LT2 (77 6 8% V̇o2max).
When controlled for exercise intensity, partial correlation
analyses show that significant correlations disappear
between gross efficiency and C/F, CAF, or fiber type,
suggesting that capillarization and fiber type allow
steady-state O2 consumptions at higher exercise in-
tensities and indirectly influence gross efficiency. Future
studies arewarranted to investigatedeterminants of gross
efficiency in greater detail.
Limiting factors for optimal combined sprint
and endurance performance
First, we discuss findings at themuscle fiber level. Second,
we discuss integration of determinants for combined
sprint and endurance performance. Fiber size and fiber
oxidative capacity were previously reported to be in-
versely related across and within animal species (25, 35).
The present study shows a similar inverse hyperbolic re-
lationship in human athletes (r = 20.50). Such inverse re-
lationship between FCSA and fV̇o2max is likely explained
by matching of muscle-fiber oxygen demand and supply.
Hill-type model predictions show that increases in ox-
ygen demand (iSDH activity = FCSA 3 fV̇o2max) may
occur, but only when accompanied by improved oxygen
diffusion from capillary blood to the core of the muscle
fiber (25). The oxygen diffusion depends on the solubility
of oxygen in muscle, diffusion coefficient for oxygen in
sarcoplasm, interstitial oxygen tension (Po2), and the
concentrationof intracellular oxygen carrierMb (71, 72). If
oxygen demand exceeds oxygen supply, the muscle fiber
will become hypoxic. Enhanced oxygen supply may ac-
commodate sustained increases in oxygendemand (iSDH
activity), by elevating interstitial Po2 to prevent the center
of the muscle fiber from becoming hypoxic at V̇o2max. Of
note, lactic acid production fromglycolyticATP synthesis
also occurs without cellular hypoxia, for instance at the
start of exercise, when phosphate and ADP concentra-
tions are low andmitochondria do not synthesize ATP at
their full oxidative capacity. To our knowledge, it has
never been tested whether, and to what extent, trained
humans are able to increase iSDH activity values. This
study shows that athletes succeeded in obtaining much
greater iSDHactivityvalues (0.14760.034 inDA660mm/s)
than untrained humans do [0.087 6 0.004 (50)] or than
patients with heart failure do [0.0486 0.004 (50)]. So, even
though muscle fiber size and oxidative capacity were in-
versely related, athletes were able to obtain high iSDH
activity values.
How well cyclists are able to combine relatively large
FCSAwithhighoxidative capacitywasassessed inabsolute
terms and relative to the group (i.e., by iSDH activity and
perpendicular residualsofFCSAandfV̇o2max, respectively).
It was expected that high oxygen demands (high iSDH
activity or high residuals) were matched by enhanced ox-
ygen supply because of enhanced oxygen supply toward
the muscle fiber, enhanced oxygen supply within the
muscle fiber, relocating mitochondria to the sarcolemma
(25). Firstly, our results show that iSDH activity and resid-
uals were positively associated with capillarization (C/F
and CAF) and likely with MCV, facilitating greater in-
terstitial PO2, reflected by higher [O2HbMb] values. Sur-
prisingly, both iSDH activity and residuals did not relate to
RBC, [Hb], and Hct, possibly because those measures ne-
glect differences in blood flow or blood volume (73). Sec-
ondly, [Mb] was not associated with iSDH activity or
residuals (P=0.16;P=0.23, respectively). This couldbedue
to the small variation in [Mb]between cyclists (coefficient of
variation ;10%). Thirdly, visual inspection of staining for
SDH activity indicated high subsarcolemmal SDH activi-
ties, particularly in type I fibers (Fig. 1). High combinations
of muscle fiber size and fiber oxidative capacity were as-
sociatedwith enhancedO2 supply toward themuscle fiber,
but not within the muscle fiber.
This study shows that combined sprint and endurance
performance of cyclists is associated with gross efficiency,
performance V̇o2, and likely with VL muscle volume and
fascicle length (Fig. 5). Performance V̇o2 is explained by
matching of O2 demand and O2 supply, preferably by
a small PCSA (Eq. 3). These findings illustrate that a
long fascicle, rather than a large PCSA, is beneficial for
achieving high POpeak + POTT, thereby avoiding the in-
verse relationship between FCSA and fV̇o2max. Although
FCSA and fV̇o2max as well as normalized sprint and en-
durance performance were inversely related (Figs. 2 and
4), their residuals were not related. Both POpeak + POTT
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and combined FCSA and fV̇o2max incorporate prediction
errors associated with their regression line, which may
explain the nonsignificant correlation. In addition,muscle
fiber number was negatively related to the residuals of
FCSA and fV̇o2max, suggesting that subjects with a large
number of muscle fibers have less need for combining a
high FCSA and fV̇o2max to develop high combined sprint
and endurance performance; they will achieve a given
PCSAwith smaller muscle FCSA.Muscle fiber number is
determined early in life because hyperplasia does not
occur in mature mammalian skeletal muscle (27, 74). Al-
though residuals of FCSA and fV̇o2maxwere not related to
POpeak + POTT, those residuals were associated with
better endurance performance and performance V̇o2 and
showed a tendency with gross efficiency, which are all
determinants of POpeak + POTT. Percentage of fast-type
fibers did not determine POpeak + POTT, likely because it
was positively related to normalized POpeak but nega-
tively related to normalized POTT. In summary, high
combined sprint and endurance performance is associ-
ated with a high gross efficiency, large muscle volume, a
muscle architecture characterized by a small PCSA and
long fascicles and a matching of oxidative capacity and
oxygen supply capacity, preferably by well-developed
capillarization.
Implications
Basedon thepresent results, keyphysiologicdeterminants
may serveas targets for trainingstrategies in sports suchas
cycling to optimize sprint and endurance performance.
Athletes, particularly those who need to combine high
sprint and endurance, are encouraged to incorporate en-
durance training and resistance training that target im-
provement of gross efficiency, oxidative capacity and
oxygen supply capacity, and muscle volume, with in-
creases in muscle fiber length rather than muscle fiber
hypertrophy. Small, but limited, increases in muscle fiber
size arepossible, but shouldbe accompaniedby enhanced
capillarization to improve both FCSA and fV̇o2max
simultaneously.
Certainly, coaches and athletes evaluate the distance at
which the athlete excels. Nevertheless, the Wingate test
and time trial provide generic measures for athletes of all
disciplines to assess their combined sprint and endurance
performance and to characterize them within the sprint–
endurance continuum. These two tests also allow time-
efficient identification of new talent and help to tune
those talents into their preferred sports discipline. The
comprehensive physiologic profile reveals the athlete’s
physiologic strengthsandweaknesseswith respect to their
sport-specific discipline, which is key to talent develop-
ment, designing individualized training strategies and
monitoring the progress of training interventions.
To optimize both sprint and endurance performance,
future studies are warranted to investigate longitudinal
effects of combined resistance and endurance training on
critical physiologic determinants and physical perfor-
mance. Training strategies to improve cycling efficiency
may include heavy or explosive resistance training (75),
but gross efficiency may also benefit from enhanced
Figure 5. Physiologic determinants of normalized sprint, endurance, and combined sprint and endurance performance.
Proportion of fast-type fibers, fascicle length, and VL muscle volume explain the variance in normalized sprint performance,
whereas performance Vȯ2, oxygen supply within the circulation (MCHC and [O2HbMb]), and gross efficiency explain the
variance in normalized endurance performance. Combined sprint and endurance performance was explained by gross
efficiency, performance Vȯ2, and likely, by VL volume and Lf. Performance Vȯ2 was explained by a high muscle-fiber oxidative
capacity, high oxygen-supply capacity toward and within the muscle fiber ([Mb] × C/F), and small muscle’s physiologic cross-
sectional area. At the muscle-fiber level, fiber size and fiber oxidative capacity were inversely related, similar to the inverse
relationship between normalized sprint and endurance performance. Several cyclists succeeded in combining high FCSA and
fVȯ2max with enhanced capillarization, whereas subjects with many muscle fibers had less need for combining a high FCSA and
fVȯ2max. These results suggest that fascicle length and capillarization may be important targets for individualized training
strategies to optimize both sprint and endurance performance.
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capillarization. Angiogenesis is induced by up-regulation
of the VEGF, which occurs with exercise [for review (76)],
especially during high-intensity training in hypoxic con-
ditions (77). High-intensity training in hypoxia also in-
creases mRNA expression of Mb (77), likely because of
local tissue hypoxia within themuscle. However, hypoxia
also attenuates the rate of translation and may result in
muscle atrophy [for review (78)]. Endurance exercise
stimulates markers for mitochondrial biogenesis, but in-
hibits activation of mTOR, which reduces muscle protein
synthesis and muscle fiber hypertrophy (24–26). Phos-
phorylation of mTOR inhibits activation of myoglobin
mRNA expression (79). It may be beneficial to focus on
lengthening of muscle fibers (i.e., the addition of sarco-
meres in series), possibly with plyometric training or ec-
centric resistance training (80, 81). Increases in Lf enhance
sprint performance, whereas it may not negatively affect
fV̇o2max necessary for a high endurance performance.
Therefore, skeletal muscle adaptations for the optimal
combination of both sprint and endurance performances
appear to be complex and require sophisticated modula-
tion of training intensity, timing, and mode in an in-
dividualized training strategy.
Limitations
This cross-sectional study reveals critical determinants of
physical performance (Fig. 5) but did not describe longi-
tudinal effects of resistance or endurance training on those
determinants. Muscle volume arrangement into PCSA
and Lf was likely suboptimal in our track sprinters and
mayhave increasedunexplainedvariance inperformance.
Additional variance may have been explained by phys-
iologic determinants that were not measured, such as
heart pumping capacity, lung diffusion and ventilation
capacity,neuromuscular recruitment (i.e., firing frequency,
synchronization, agonist–antagonist activity), muscle
metabolites [e.g., phosphocreatine,muscle lactate, inosine
59-monophosphate (IMP)], muscle tendon moment arm,
tendon elasticity, or glycogen availability. Those vari-
ables may explain additional variance in combined
sprint and endurance performance, whereas assessed
physiologic determinants already explained a large
proportion of variance in endurance and sprint per-
formance in the present study.
CONCLUSIONS
This study integrated physiologic performance determi-
nants from single muscle fibers to whole-body biologic
levels and showed that normalized sprint performance
wasexplainedby thepercentageof fast-type fibers, fascicle
length, and muscle volume of the vastus lateralis. Perfor-
mance V̇o2 and oxygen supply within the circulation
(MCHCand [O2HbMb]) critically determined normalized
endurance performance. Combined sprint and endurance
performance was explained by gross efficiency, perfor-
mance V̇o2 (i.e., high oxidative capacity, a well-developed
oxygen supply capacity, and small PCSA), and likely VL
volume and Lf. The results suggest that, in sports such as
cycling, fascicle length and capillarization may be impor-
tant training targets to optimize sprint and endurance
performance simultaneously.
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